adalimumab

Crohn’s disease treatment market sees major shift with biosimilars and next-gen therapies: GlobalData

Read more

Humira biosimilar to see $832 million in sales by 2029: GlobalData

Read more

Enzene Biosciences begins commercial supply of its biosimilar of Adalimumab

Read more

Cadila Pharma launches Cadalimab (adalimumab biosimilar) for India

Read more

Anti-TNF therapies could treat patients with COVID-19-related ARDS

Read more